Javascript must be enabled to continue!
In Silico and Experimental Analyses of Long Non-Coding RNA TMPO-AS1 Expression in Gastric Cancer Tissues
View through CrossRef
Abstract
Background
A large body of evidence has illustrated the prominent roles of non-coding RNAs, particularly long non-coding RNAs (lncRNAs), in cancer progression and diagnosis. In this study, we considered in silico and experimental analyses of long non-coding TMPO-AS1 expression in adjacent nonmalignant tissues and cancerous tissues of the patients with gastric cancer.
Methods
In order to conduct the present study, 40 gastric tumor samples and 40 marginal noncancerous counterparts were collected. The TMPO-AS1 expression levels in patients’ samples were evaluated by qRT-PCR analysis. The Cancer Genome Atlas (TCGA) data were retrieved for TMPO-AS1 and analyzed via Gepia and TANRIC online tools. Student t-test, one-way ANOVA, and chi-square test were accomplished via SPSS software.
Results
The data demonstrated that TMPO-AS1 was overexpressed in cancerous tissues compared to nonmalignant adjacent ones (p: 0.0076). The TCGA data demonstrated that TMPO-AS1 was upregulated in GC tissues in comparison to nonmalignant adjacent ones (p = 0.001).
Conclusion
Altogether, in our study, we demonstrated lncRNA TMPO-AS1 could be considered as a biomarker in GC.However, further investigations are required to indicate the potential application of this lncRNA in diagnosis, prognosis and therapeutic target of GC.
Research Square Platform LLC
Title: In Silico and Experimental Analyses of Long Non-Coding RNA TMPO-AS1 Expression in Gastric Cancer Tissues
Description:
Abstract
Background
A large body of evidence has illustrated the prominent roles of non-coding RNAs, particularly long non-coding RNAs (lncRNAs), in cancer progression and diagnosis.
In this study, we considered in silico and experimental analyses of long non-coding TMPO-AS1 expression in adjacent nonmalignant tissues and cancerous tissues of the patients with gastric cancer.
Methods
In order to conduct the present study, 40 gastric tumor samples and 40 marginal noncancerous counterparts were collected.
The TMPO-AS1 expression levels in patients’ samples were evaluated by qRT-PCR analysis.
The Cancer Genome Atlas (TCGA) data were retrieved for TMPO-AS1 and analyzed via Gepia and TANRIC online tools.
Student t-test, one-way ANOVA, and chi-square test were accomplished via SPSS software.
Results
The data demonstrated that TMPO-AS1 was overexpressed in cancerous tissues compared to nonmalignant adjacent ones (p: 0.
0076).
The TCGA data demonstrated that TMPO-AS1 was upregulated in GC tissues in comparison to nonmalignant adjacent ones (p = 0.
001).
Conclusion
Altogether, in our study, we demonstrated lncRNA TMPO-AS1 could be considered as a biomarker in GC.
However, further investigations are required to indicate the potential application of this lncRNA in diagnosis, prognosis and therapeutic target of GC.
Related Results
Investigating the expression of LNCRNAs TMPO-AS1, DDX11-AS1, and POLE gene in head and neck squamous cell carcinoma
Investigating the expression of LNCRNAs TMPO-AS1, DDX11-AS1, and POLE gene in head and neck squamous cell carcinoma
Abstract
Background and aim: Head and neck cancer includes all cancers located in the head and neck area, including larynx, oral cavity, nasal cavities, lips, myopic sinuse...
P041 CDKN2B-AS1 (ANRIL) expression is decreased in Inflammatory Bowel Disease epithelia and in Celiac, and its reduction is linked with induced cells proliferation
P041 CDKN2B-AS1 (ANRIL) expression is decreased in Inflammatory Bowel Disease epithelia and in Celiac, and its reduction is linked with induced cells proliferation
Abstract
Background
Long non-coding RNAs (lncRNAs) have attenuated expression in several immune-mediated disorders. Using mRNAse...
LncRNA EPB41L4A-AS1 Regulates Cell Proliferation, Apoptosis and Metastasis in Breast Cancer
LncRNA EPB41L4A-AS1 Regulates Cell Proliferation, Apoptosis and Metastasis in Breast Cancer
Abstract
Background: Breast cancer is a leading global public health problem. In our previous study, we identified that lncRNA EPB41L4A antisense RNA 1 (EPB41L4A-AS1) was s...
Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer
Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer
Abstract
Background: Trastuzumab has been widely used for treatment of HER-2-positive breast cancer patients, however, the clinical response has been restricted due to emer...
STK4 antisense RNA 1-p53 affects osteosarcoma
STK4 antisense RNA 1-p53 affects osteosarcoma
Abstract
Background
LncRNA STK4 antisense RNA 1(STK4-AS1) has been identified as a potential biomarker associated with multiple cancers. We proposed that STK4-AS1 plays a ...
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
Background:
Hepatocellular carcinoma (HCC) is one of the most deadly cancer types worldwide, and
its incidence is high in China. Multiple long non-coding RNAs (lncRNAs) have been r...
lncRNA ABHD11-AS1 drives gastric cancer development by targeting miR-1301-3p/PDPK1 signaling
lncRNA ABHD11-AS1 drives gastric cancer development by targeting miR-1301-3p/PDPK1 signaling
Abstract
Background
Long noncoding RNAs (lncRNAs) has long been reported to associate with multitudinous kinds of cancer. The ABHD11-AS1, a newly identified lncRNAs, has b...
CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1
CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1
AbstractAberrant expression of long noncoding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) has been detected in human colorectal cancer (CRC). This study a...

